Diabetes Board decisions

The Veteran's claim for SMC based on the need for aid and attendance prior to December 15, 2021 was denied as there is no evidence showing he required regular aid and assistance due to his service-connected disabilities.

The Board dismissed the appeals for service connection for chronic fatigue syndrome, migraine headache with sensitivity to noise, and Type II diabetes mellitus due to an administrative error that resulted in duplicative claims.

The Veteran's radiculopathy of the left lower extremity was granted an increased rating to 40 percent, and his service connection claim for dementia was denied. Other claims were remanded.

The Veteran's diabetes mellitus, type II, is service connected due to herbicide exposure.,His peripheral neuropathy of the right and left lower extremities are secondary to his diabetes mellitus.

The Board has granted service connection for atherosclerotic cardiovascular disease, diabetes mellitus type II (DM), and diabetic peripheral neuropathy in the upper and lower extremities prior to August 10, 2022. The claims were based on direct service connection due to chemical exposure during active duty.

The Board granted service connection for diabetes mellitus, type II, finding that it is proximately due to the Veteran's service-connected obstructive sleep apnea.

The Board has denied service connection for lung condition, kidney condition, diabetes mellitus type II, erectile dysfunction (ED), left knee condition, right knee condition, and hypertension.

The Veteran's claim for service connection for diabetes mellitus, secondary to his service-connected bilateral leg conditions and obesity, is being remanded due to the lack of an adequate medical opinion.

The Board denied the Veteran's claims for increased ratings for type II diabetes mellitus and coronary artery disease with myocardial infarction, finding that the evidence did not support an increase in disability rating beyond the currently assigned 20 percent and 30 percent evaluations.

The Veteran's cardiomyopathy is found to be the result of his service-connected diabetes mellitus, type II. Service connection for cardiomyopathy as secondary to diabetes mellitus is granted.

The Board has decided to remand the claim for further development due to duty to assist errors and potential secondary service connection issues.

The Veteran's service-connected disabilities did not render him unemployable prior to August 10, 2022. Beginning August 10, 2022, his combined disability rating is 100 percent and the issue of TDIU is dismissed as moot due to the presence of other service-connected disabilities.

The Board denied service connection for right knee septic arthritis, seizures, hypertension, and diabetes mellitus as the evidence did not support a finding of a nexus between these conditions and the Veteran's military service. The left knee condition was remanded for further development.

The Board has decided to remand the case due to insufficient evidence regarding whether the Veteran's service-connected right knee disability caused or aggravated his obesity, which in turn led to diabetes mellitus, type II.

The Veteran withdrew his appeal in its entirety prior to the promulgation of a decision.

The Board has denied service connection for obstructive sleep apnea and type II diabetes mellitus, both claimed as secondary to service-connected PTSD. The evidence does not support a causal relationship between the Veteran's conditions and his service-connected PTSD.

The Veteran's travel to a VA medical appointment on May 8, 2024, was related to his service-connected diabetes mellitus. As the treatment was for a service-connected condition, he is eligible for reimbursement of beneficiary travel.

The Veteran's appeal for service connection for diabetes mellitus was withdrawn. An effective date of October 30, 2017, and not earlier, is granted for the award of service connection for PTSD.

The Veteran's gastroesophageal reflux disease is granted a 30 percent rating. The ratings for his left and right lower extremity radiculopathy and diabetic peripheral neuropathy are denied.

The Board remands the claims for service connection for diabetes mellitus type II and hypertension to satisfy a regulatory duty under the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 (PACT Act).